
CNS Summit is a community founded in 2010 by life sciences leaders to drive positive change in patient outcomes through innovation, collaboration, and technology. It convenes over 1,000 decision-makers from across the life sciences ecosystem, including pharma, biotech, CROs, regulatory authorities, and patient advocates. The annual CNS Summit event and year-round programming offer curated networking, access to emerging technologies, and opportunities for collaborative professional relationships. The community focuses on advancing drug development through discussions on topics like AI, digital biomarkers, real-world evidence, and decentralized trials.

CNS Summit is a community founded in 2010 by life sciences leaders to drive positive change in patient outcomes through innovation, collaboration, and technology. It convenes over 1,000 decision-makers from across the life sciences ecosystem, including pharma, biotech, CROs, regulatory authorities, and patient advocates. The annual CNS Summit event and year-round programming offer curated networking, access to emerging technologies, and opportunities for collaborative professional relationships. The community focuses on advancing drug development through discussions on topics like AI, digital biomarkers, real-world evidence, and decentralized trials.